Pimples happen when a tiny hole in your skin gets blocked with oil and old skin, and then little germs get stuck inside. Your body sends help to fight the germs, and that fight makes the red, sore bump you can see. A red light mask helps in two ways. The blue light scares away the germs. The red light helps the angry redness calm down.
It is not magic. It works best on the small red pimples that lots of people get. The really big sore lumps deep under the skin need a doctor. But for everyday pimples, wearing a red and blue mask a few times a week can help you get fewer of them, without making your skin all dry and flaky.
Combined blue and red light is one of the most consistently evidenced LED uses.
Papageorgiou et al. 2000 (RCT, 107 patients) reported 76% mean improvement in inflammatory acne lesions at twelve weeks with combined blue and red light, outperforming both blue alone and benzoyl peroxide. Lee et al. 2007 reported 77.93% improvement with combined 415nm blue and 633nm red. Akuffo-Addo et al. 2024 reviewed 35 studies covering 1,185 patients and recorded high rates of partial remission or clearance with visible-light therapy. Inflammatory acne (papules and pustules) responds; severe nodulocystic acne and structural scarring need clinician-guided care.
Why red and blue light are studied together for acne
Inflammatory acne involves two parallel processes. The first is bacterial colonisation of the sebaceous follicle by Cutibacterium acnes (formerly Propionibacterium acnes). The second is a downstream inflammatory cascade triggered by that colonisation, which produces the visible papules, pustules, and redness. LED therapy in the visible spectrum is studied to address both arms of the problem.
Blue light at around 415 nanometres is absorbed by porphyrins inside C. acnes bacteria. The absorbed photons trigger a photodynamic reaction that produces reactive oxygen species inside the bacterial cells, which reduces bacterial load on the skin. This is the bacterial mechanism. Red light at 630 to 660nm is absorbed by mitochondrial cytochrome c oxidase in skin cells, which lifts ATP production and modulates the inflammatory response. This is the anti-inflammatory mechanism.
Combined protocols target both mechanisms in the same session. The trial evidence consistently shows the combination outperforming either wavelength used alone, which is why the canonical acne protocols in published research use blue plus red rather than either in isolation.
The strongest evidence
Three trials and reviews carry most of the weight on inflammatory acne. We walk through each, then summarise the supporting meta-analyses behind them.
Papageorgiou et al. 2000: 76% improvement at 12 weeks
Papageorgiou and colleagues (PMID 10809858, British Journal of Dermatology) ran a randomized controlled trial in 107 patients with mild to moderate acne vulgaris. Participants were randomized into four arms: blue light alone (415nm), red light alone, combined blue plus red light (415 plus 660nm), and a 5% benzoyl peroxide cream control. The benzoyl peroxide arm matters because BP is a standard over-the-counter acne intervention with a well-documented effect size, which made it a meaningful comparator rather than a placebo.
Sessions ran daily over 12 weeks. Outcomes were measured by inflammatory lesion counts at baseline, four, eight, and twelve weeks, alongside investigator-assessed photographs. The combined blue plus red light arm produced 76% mean improvement in inflammatory lesions at 12 weeks. That number outperformed blue light alone (which itself was effective), and outperformed benzoyl peroxide. This trial is the foundational reference in the home-use LED literature for inflammatory acne. It set the wavelength combination, the session frequency, and the 12-week timeline that subsequent trials built on.
Lee et al. 2007: 78% improvement in skin phototype IV patients
Lee and colleagues (PMID 17111415, Lasers in Surgery and Medicine) ran a prospective clinical trial of combined 415nm blue and 633nm red LED phototherapy in patients with skin phototype IV. The skin phototype detail matters: most acne LED literature has historically over-represented skin phototypes II and III. Phototype IV patients tend to have higher post-inflammatory hyperpigmentation risk, which makes them a particularly relevant cohort for LED therapy where the alternative interventions can leave more pigmentation.
Outcomes were measured by lesion counts at baseline and after the treatment course. The combined wavelength protocol produced mean improvements of 34.28% in non-inflammatory lesions and 77.93% in inflammatory lesions. The inflammatory number is the headline and aligns closely with the Papageorgiou 2000 result, despite the different demographic. The non-inflammatory number is smaller, which is consistent with the broader pattern in the literature: LED therapy is more effective on inflammatory lesions than on comedonal ones because the mechanism targets bacterial load and inflammation rather than follicular keratinisation.
Akuffo-Addo et al. 2024: high partial-remission rates across 35 studies
Akuffo-Addo and colleagues (PMID 39056372, Journal of Cutaneous Medicine and Surgery) published a systematic review of 35 studies and 1,185 patients on visible light therapy in acne vulgaris. Systematic reviews aggregate trial data across the field rather than running a new trial, which lets the reader see what the body of evidence as a whole supports rather than what any single trial reports.
The review reported that the studies it included documented high rates of partial remission or clearance with visible-light therapy across the 1,185 patients. Blue light was the most commonly used modality, present in roughly two thirds of the included studies. These are aggregate review findings rather than direct expected outcomes for any single user, but they document that the trial-level effect sizes reported by Papageorgiou 2000 and Lee 2007 generalise across patient demographics, study designs, and protocol variations. The review also documents that the safety profile across the literature is strong, with low rates of adverse events.
Supporting evidence
Two additional reviews extend the pattern. Scott et al. 2019 (PMID 31712293) ran a systematic review and meta-analysis in Annals of Family Medicine across 14 RCTs and 698 participants. The review found multiple trials demonstrating benefit and confirmed that visible light therapy is safe with low adverse event rates. Ngoc et al. 2023 (PMID 36310510) ran a meta-analysis on LED therapy in skin rejuvenation and acne, reporting a statistically significant standardized mean difference of -2.42 for the red and blue LED combination in acne outcomes. The supporting reviews don't change the conclusion of the primary trials. They reinforce that the effect sizes are real, replicable, and generalise across study designs.
The practical timeline
The acne trials converge on a slightly faster rhythm than the wrinkle literature, but the full readout still settles around 12 weeks.
In the first two to three weeks, expect reduced inflammation and redness on existing active lesions. Bacterial load reduction from blue light begins early in the course, and the anti-inflammatory effect of red light supports recovery on lesions that are already present. Some users notice their active lesions resolving slightly faster than they normally would.
By weeks four to six, new lesion frequency typically starts to decline. This is when the cumulative effect on bacterial load and follicular environment shows up as fewer breakouts rather than just faster resolution of existing ones. Inflammatory lesion counts in trials usually drop notably by this point.
Weeks 8 to 12 is when the full effect lands. Papageorgiou 2000's 76% number was measured at 12 weeks. Inflammatory lesion counts have stabilised at their lower level by this point, and post-inflammatory marks (the brown or red marks left after lesions resolve) start to fade. Beyond 12 weeks, maintenance use at one to two sessions per week becomes appropriate to protect the gains.
When LED therapy is the wrong tool
LED therapy is not a substitute for clinician-guided care of severe acne.
Severe nodulocystic acne (deep, painful, often scarring lesions) needs medical evaluation. Cystic acne can leave permanent scarring without appropriate intervention, and the published LED literature does not support its use as a sole treatment in this category. Hormonally-driven persistent acne in adult women may need investigation of underlying hormonal patterns that LED therapy cannot address. Acne unresponsive to over-the-counter approaches across several months should be evaluated rather than escalated with LED alone.
In all of those cases, LED therapy may still be a useful adjunct alongside a clinician-prescribed regimen. The evidence supports it as a complementary tool, not a primary intervention. Many dermatologists now incorporate at-home LED into broader acne treatment plans, particularly for the inflammatory and post-inflammatory phases.
For texture changes left by past acne, see our skin texture guide. Surface marks from past inflammation tend to respond to LED. Atrophic ice-pick scars are structural and rarely respond to LED alone.
How our mask fits in
We built our mask around the wavelength categories represented in the canonical acne trials. It runs 415nm blue, 633nm red, 590nm yellow, and dual near-infrared at 850nm and 1072nm across six preset modes. The mask includes a dedicated Anti-Acne preset, which is the blue light mode. The broader acne literature often studies blue plus red combinations, and Red Light Rejuve also includes red in other modes, but the Anti-Acne preset itself should be described as blue light.
Three hundred and sixty medical-grade LEDs cover the full mask surface, which means the bacterial-load and inflammatory pathways get coverage across forehead, cheeks, jaw, and chin in a single 10-minute session. Sixty-day money-back guarantee. Two-year warranty. Free express shipping AU-wide. For active inflammatory acne, LED is best used as part of a routine that may include topical or clinician-prescribed care, not as a stand-alone fix.
Cited studies
Papageorgiou P, Katsambas A, Chu A · British Journal of Dermatology · 2000 · PMID 10809858
“Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris”
Combined blue-red light achieved 76% mean improvement in inflammatory lesions after 12 weeks, outperforming blue light alone and benzoyl peroxide.
View on PubMed →Lee SY, You CE, Park MY · Lasers in Surgery and Medicine · 2007 · PMID 17111415
“Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV”
Mean improvements of 34.28% (non-inflammatory) and 77.93% (inflammatory lesions) with combined blue+red LED.
View on PubMed →Akuffo-Addo E, et al. · Journal of Cutaneous Medicine and Surgery · 2024 · PMID 39056372
“Visible Light in the Treatment of Acne Vulgaris”
92% of 1,185 patients across 35 studies achieved partial remission; blue light used in 64% of cases with 95% partial clearance rate.
View on PubMed →Scott AM, et al. · Annals of Family Medicine · 2019 · PMID 31712293
“Blue-Light Therapy for Acne Vulgaris: A Systematic Review and Meta-Analysis”
14 RCTs (698 participants) reviewed; some trials show benefit; blue light is safe with low adverse event rates.
View on PubMed →Ngoc LTN, et al. · Photodermatology, Photoimmunology & Photomedicine · 2023 · PMID 36310510
“Utilization of light-emitting diodes for skin therapy: Systematic review and meta-analysis”
Meta-analysis confirmed that red and NIR LEDs significantly improved skin rejuvenation outcomes; red and blue LED combination showed statistically significant SMD of -2.42 for acne.
View on PubMed →
See our full research database for the complete catalogue of peer-reviewed studies.
FAQ
Does red light therapy work for acne on its own, or only with blue light?
The largest reported effect sizes for inflammatory acne come from combined red and blue light protocols. Red light at 630 to 660 nanometres targets inflammation and supports tissue recovery. Blue light at around 415 nanometres targets the bacterial component. Some trials test red light alone with smaller positive effects, but the combination consistently outperforms either wavelength used in isolation.
What kind of acne responds best?
Inflammatory acne (papules and pustules) has the strongest evidence base in the LED literature. Comedonal acne (whiteheads and blackheads) shows smaller effect sizes in trials. Severe nodulocystic acne, hormonal acne unresponsive to over-the-counter products, and persistent acne with scarring should be evaluated by a clinician. LED therapy is best used alongside a clinician-guided plan in those cases, not as a sole approach.
How long until acne improves?
Trials generally report meaningful inflammatory-lesion reduction across 4 to 12 weeks of consistent use, typically at two to three sessions per week. Papageorgiou 2000 measured at 12 weeks with their headline 76% number. Some users report visible reduction in active lesion count earlier in the course, but the more reliable readout window is the same 8 to 12 week range that anchors most home-use LED literature.
Can I use LED with retinoids or benzoyl peroxide?
Use the mask on clean, dry skin without active products on the face during the session itself. Apply skincare after, when the skin is in renewal mode. Photosensitising actives applied immediately before a session can increase irritation, so space them out by several hours or apply at a different time of day. If you're on prescription tretinoin or topical antibiotics, consult your prescribing clinician on how to layer LED into your routine.
Does the Red Light Rejuve mask emit blue light?
Yes. The mask includes 415nm blue and a dedicated Anti-Acne preset. The broader acne literature often studies blue plus red combinations, and Red Light Rejuve also includes 633nm red in other modes, but the Anti-Acne preset itself should be described as blue light. Users can run the Anti-Acne preset on its own, or rotate to a red-inclusive mode like Repairing or Bedtime Skincare in a separate session if they want to layer in red wavelengths around the active acne phase.
Related guides
- Red light therapy for skin texture
Recovery from past inflammation and post-acne texture.
- Red light therapy for collagen
The supporting mechanism behind skin-recovery effects.
- Red light therapy for wrinkles
Effect sizes from the strongest randomized trials.
- Customer reviews
Real-user outcomes from Australian customers.
A multi-wavelength mask with a dedicated Anti-Acne preset.
Red Light Rejuve includes 415nm blue, 633nm red, 590nm yellow, and dual near-infrared at 850nm and 1072nm across six preset modes. The Anti-Acne preset itself is the blue light mode, with red wavelengths available in other modes. 60-day money-back guarantee, two-year warranty.